Stable phenotype and function of immortalized Lin-Sca-1 + cardiac progenitor cells in long-term culture: A step closer to standardization

Stem Cells and Development

Volumn 23, Issue 9, 2014, Pages 1012-1026

  Freire, Ana G ^a,b   Nascimento, Diana S ^a   Forte, Giancarlo ^c,d   Valente, Mariana ^a,b   Resende, Tatiana P ^a   Pagliari, Stefania ^c,d   Abreu, Cláudia ^b   Carvalho, Isabel ^e   Nardo, Paolo Di ^c   Pinto Do Ó, Perpétua ^a,b  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENGINEERING; CARDIAC PROGENITOR CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL RENEWAL; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STANDARDIZATION; STEM CELL; STEM CELL CULTURE; STEM CELL TRANSPLANTATION; ANGIOGENESIS; ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; GRAFT SURVIVAL; HEART MUSCLE; METABOLISM; MYOCARDIAL INFARCTION; PROCEDURES; STANDARDS; TRANSFORMED CELL LINE;

LY ANTIGEN; LY6A PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMALS; ANTIGENS, LY; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; GRAFT SURVIVAL; MEMBRANE PROTEINS; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84896901797     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0305     Document Type: Article

References (59)

1. Bui QT, ZM Gertz and RL Wilensky. (2010). Intracoronary delivery of bone-marrow-derived stem cells. Stem Cell Res Ther 1:29.
2. Muller-Ehmsen J, B Krausgrill, V Burst, K Schenk, UC Neisen, JW Fries, BK Fleischmann, J. Hescheler and RH Schwinger. (2006). Effective engraftment but poor midterm persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41:876-884.
3. Gnecchi M, H He, OD Liang, LG Melo, F Morello, H Mu, N Noiseux, L Zhang, RE Pratt, JS Ingwall and VJ Dzau. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367-368.
4. Kinnaird T, E Stabile, MS Burnett, M Shou, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549.
5. Wang X, Q Hu, Y Nakamura, J Lee, G Zhang, AH From and J Zhang. (2006). The role of the sca-1+/CD31 - cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 24:1779-1788.
6. Beltrami AP, L Barlucchi, D Torella, M Baker, F Limana, S Chimenti, H Kasahara, M Rota, E Musso, et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776.
7. Chong JJ, V Chandrakanthan, M Xaymardan, NS Asli, J Li, I Ahmed, C Heffernan, MK Menon, CJ Scarlett, et al. (2011). Adult cardiac-resident msc-like stem cells with a proepicardial origin. Cell Stem Cell 9:527-540.
8. Gambini E, G Pompilio, A Biondi, F Alamanni, MC Capogrossi, M Agrifoglio and M Pesce. (2011). C-kit + cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. Cardiovasc Res 89:362-373.
9. Hierlihy AM, P Seale, CG Lobe, MA Rudnicki and LA Megeney. (2002). The post-natal heart contains a myocardial stem cell population. FEBS Lett 530:239-243.
10. Martin CM, AP Meeson, SM Robertson, TJ Hawke, JA Richardson, S Bates, SC Goetsch, TD Gallardo and DJ Garry. (2004). Persistent expression of the ATP binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 265: 262-275.
11. Messina E, L De Angelis, G Frati, S Morrone, S Chimenti, F Fiordaliso, M Salio, M Battaglia, MV Latronico, et al. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95:911-921.
12. Oh H, SB Bradfute, TD Gallardo, T. Nakamura, V. Gaussin, Y Mishina, J Pocius, LH Michael, RR Behringer, et al. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100:12313-12318.
13. Pfister O, F Mouquet, M Jain, R Summer, M Helmes, A Fine, WS Colucci and R Liao. (2005). CD31- but not CD31 + cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 97:52-61.
14. Smart N, S Bollini, KN Dube, JM Vieira, B Zhou, S Davidson, D Yellon, J Riegler, AN Price, et al. (2011). De novo cardiomyocytes from within the activated adult heart after injury. Nature 474:640-644.
15. + cardiac progenitor cells for myocardial regeneration. PLoS One 6:e25265.
16. Tateishi K, E Ashihara, N Takehara, T Nomura, S Honsho, T Nakagami, S Morikawa, T Takahashi, T Ueyama, H Matsubara and H Oh. (2007). Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J Cell Sci 120: 1791-1800.
17. Yamahara K, S Fukushima, SR Coppen, LE Felkin, A Varela-Carver, PJR Barton, MH Yacoub and K Suzuki. (2008). Heterogeneic nature of adult cardiac side population cells. Biochem Biophys Res Commun 371:615-620.
18. + cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury. PLoS One 7:e30329.
19. Bolli R, AR Chugh, D D'Amario, JH Loughran, MF Stoddard, S Ikram, GM Beache, SG Wagner, A Leri, et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:1847-1857.
20. Lim GB. (2012). Stem cells: myocardial regeneration after infarction-promising phase I trial results. Nat Rev Cardiol 9:187.
21. Di Nardo P, G Forte, A Ahluwalia and M Minieri. (2010). Cardiac progenitor cells: potency and control. J Cell Physiol 224:590-600.
22. Di Nardo P and GC Parker. (2011). Stem cell standardization. Stem Cells Dev 20:375-377.
23. Dawn B and R Bolli. (2005). Cardiac progenitor cells. Circ Res 97:1080-1082.
24. Gonzalez A, M Rota, D Nurzynska, Y Misao, J Tillmanns, C Ojaimi, ME Padin-Iruegas, P Müller, G Esposito, et al. (2008). Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res 102:597-606.
25. Hooijberg E, JJ Ruizendaal, PJF Snijders, EWM Kueter, JMM Walboomers and H Spits. (2000). Immortalization of human CD8 + T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol 165:4239-4245.
26. Simonsen JL, C Rosada, N Serakinci, J Justesen, K Stenderup, SIS Rattan, TG Jensen and M Kassem. (2002). Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592-596.
27. Yang J, E Chang, AM Cherry, CD Bangs, Y Oei, A Bodnar, A Bronstein, C-P Chiu and GS Herron. (1999). Human endothelial cell life extension by telomerase expression. J Biol Chem 274:26141-26148.
28. Jiang X-R, G Jimenez, E Chang, M Frolkis, B Kusler, M Sage, M Beeche, AG Bodnar, GM Wahl, TD Tlsty and C-P Chiu. (1999). Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21:111-114.
29. Forte G, F Carotenuto, F Pagliari, S Pagliari, P Cossa, R Fiaccavento, A Ahluwalia, G Vozzi, B Vinci, et al. (2008). Criticality of the biological and physical stimuli array inducing resident cardiac stem cell determination. Stem Cells 26:2093-2103.
30. Schou M and A-M Engel. (2006). Assay of tumorigenicity in nude mice. In: Cell Biology: a laboratory handbook. JE Cells, ed. Elsevier Science, pp 353-357.
31. Wu G-J, P Fu, S-W Wang and M-WH Wu. (2008). Enforced expression of MCAM/MUC18 Increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model. Mol Cancer Res 6:1666-1677.
32. Smits AM, P van Vliet, CH Metz, T Korfage, JPG Sluijter, PA Doevendans and M-J Goumans. (2009). Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 4:232-243.
33. Pagliari S, AC Vilela-Silva, G Forte, F Pagliari, C Mandoli, G Vozzi, S Pietronave, M Prat, S Licoccia, et al. (2011). Cooperation of biological and mechanical signals in cardiac progenitor cell differentiation. Adv Mater 23:514-518.
34. Michael LH, ML Entman, CJ Hartley, KA Youker, J Zhu, SR Hall, HK Hawkins, K Berens and CM Ballantyne. (1995). Myocardial ischemia and reperfusion: a murine model. Am J Physiol 269:H2147-H2154.
35. Nascimento DS, M Valente, T Esteves, F de Pina Mde, JG Guedes, A Freire, P Quelhas and P Pinto-do-Ó. (2011). MIQuant: semi-automation of infarct size assessment in models of cardiac ischemic injury. PLoS One 6:e25045.
36. Bhattacharyya S, A Kumar and K Lal Khanduja. (2012). The voyage of stem cell toward terminal differentiation: a brief overview. Acta Biochim Biophys Sin (Shanghai) 44:463-475.
37. Cottage CT, B Bailey, KM Fischer, D Avitable, B Collins, S Tuck, P Quijada, N Gude, R Alvarez, J Muraski and MA Sussman. (2010). Cardiac progenitor cell cycling stimulated by Pim-1 kinase. Circ Res 106:891-901.
38. Garbade J, A Schubert, AJ Rastan, D Lenz, T Walther, JF Gummert, S Dhein and F-W Mohr. (2005). Fusion of bone marrow-derived stem cells with cardiomyocytes in a heterologous in vitro model. Eur J Cardio-Thorac Surg 28:685-691.
39. Wurmser AE and FH Gage. (2002). Stem cells: cell fusion causes confusion. Nature 416:485-487.
40. Liang SX, TYL Tan, L Gaudry and B Chong. (2010). Differentiation and migration of Sca1 +/CD31 - cardiac side population cells in a murine myocardial ischemic model. Int J Cardiol 138:40-49.
41. Baum J and HS Duffy. (2011). Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol 57:376-379.
42. Lajiness JD and SJ Conway. (2013). Origin, development, and differentiation of cardiac fibroblasts. J Mol Cell Cardiol pii:S0022-2828.
43. Plotkin M and V Mudunuri. (2008). Pod1 induces myofibroblast differentiation in mesenchymal progenitor cells from mouse kidney. J Cell Biochem 103:675-690.
44. Matsuura K, A Honda, T Nagai, N Fukushima, K Iwanaga, M Tokunaga, T Shimizu, T Okano, H Kasanuki, N Hagiwara and I Komuro. (2009). Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119:2204-2217.
45. Macieira-Coelho A, E Loria and L Berumen. (1975). Relationship between cell kinetic changes and metabolic events during cell senescence in vitro. Adv Exp Med Biol 53:51-65.
46. Sherr CJ and RA DePinho. (2000). Cellular senescence: minireview mitotic clock or culture shock? Cell 102:407-410.
47. Tolar J, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, S Bell, L Xia, N Zhou, M Riddle, et al. (2007). Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25:371-379.
48. Armstrong L, G Saretzki, H Peters, I Wappler, J Evans, N Hole, T von Zglinicki and M Lako. (2005). Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 23:516-529.
49. Forte G, O Franzese, S Pagliari, F Pagliari, AM Di Francesco, P Cossa, A Laudisi, R Fiaccavento, M Minieri, E Bonmassar and P Di Nardo. (2009). Interfacing Sca-1(pos) mesenchymal stem cells with biocompatible scaffolds with different chemical composition and geometry. J Biomed Biotechnol 2009:910610.
50. Geserick C, A Tejera, E Gonzalez-Suarez, P Klatt and MA Blasco. (2006). Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene 25: 4310-4319.
51. Lee MK, MP Hande and K Sabapathy. (2005). Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J Cell Sci 118:819-829.
52. Steele SL, Y Wu, RJ Kolb, M Gooz, CJ Haycraft, KT Keyser, L Guay-Woodford, H Yao and PD Bell. (2010). Telomerase immortalization of principal cells from mouse collecting duct. Am J Physiol Renal Physiol 299:F1507-F1514.
53. Miranda CO, CA Teixeira, MA Liz, VF Sousa, F Franquinho, G Forte, P Di Nardo, OP Pinto-Do and MM Sousa. (2011). Systemic delivery of bone marrow-derived mesenchymal stromal cells diminishes neuropathology in a mouse model of Krabbe's disease. Stem Cells 29:1738-1751.
54. Harley CB. (2002). Telomerase is not an oncogene. Oncogene 21:494-502.
55. Prescott JC and EH Blackburn. (1999). Telomerase: Dr. Jekyll or Mr. Hyde? Curr Opin Genet Dev 9:368-373.
56. Denhardt DT, DR Edwards, M McLeod, G Norton, CLJ Parfett and M Zimmer. (1991). Spontaneous immortalization of mouse embryo cells: strain differences and changes in gene expression with particular reference to retroviral gag-pol genes. Exp Cell Res 192:128-136.
57. Fusenig NE, RT Dzarlieva-Petrusevska and D Breitkreutz. (1985). Phenotypic and cytogenetic characteristics of different stages during spontaneous transformation of mouse keratinocytes in vitro. Carcinog Compr Surv 9: 293-326.
58. Wang D, W Shen, F Zhang, M Chen, H Chen and K Cao. (2010). Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. Cell Biol Int 34: 415-423.
59. Roell W, T Lewalter, P Sasse, YN Tallini, B-R Choi, M Breitbach, R Doran, UM Becher, S-M Hwang, et al. (2007). Engraftment of connexin 43-expressing cells prevents postinfarct arrhythmia. Nature 450:819-824.